| Dr Theddeus Iheanacho, MD | |
|
203 Broad St, Suite C-4, Milford, CT 06460-4751 | |
| (203) 874-0593 | |
| (203) 877-8053 |
| Full Name | Dr Theddeus Iheanacho |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 26 Years |
| Location | 203 Broad St, Milford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922312503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 258158 (New York) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 49777 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charter Oak Health Center, Inc | 3870401078 | 33 |
| Trinity Health Of New England Provider Network Organization Inc | 0941113567 | 621 |
News Archive
Orthofix International announced today that its Sports Medicine Division, Breg, has launched the FUSION® XT knee brace with its innovative new AirTech™ system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.
British doctors are about to conduct the first major trial of "spray-on" skin after the technique saved the life of a man with 90 per cent burns.
In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration found significant gaps in participation among those aged 75 and older when considered against the incidence of these malignancies in this age group, according to research being presented today during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation treatment," which has attracted intense interest in the global MS community, does not improve patient outcomes. In a few cases, the treatment made symptoms worse.
› Verified 8 days ago
| Entity Name | Trinity Health Of New England Provider Network Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003882812 PECOS PAC ID: 0941113567 Enrollment ID: O20031110000651 |
News Archive
Orthofix International announced today that its Sports Medicine Division, Breg, has launched the FUSION® XT knee brace with its innovative new AirTech™ system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.
British doctors are about to conduct the first major trial of "spray-on" skin after the technique saved the life of a man with 90 per cent burns.
In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration found significant gaps in participation among those aged 75 and older when considered against the incidence of these malignancies in this age group, according to research being presented today during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation treatment," which has attracted intense interest in the global MS community, does not improve patient outcomes. In a few cases, the treatment made symptoms worse.
› Verified 8 days ago
| Entity Name | Charter Oak Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992750855 PECOS PAC ID: 3870401078 Enrollment ID: O20040220000909 |
News Archive
Orthofix International announced today that its Sports Medicine Division, Breg, has launched the FUSION® XT knee brace with its innovative new AirTech™ system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.
British doctors are about to conduct the first major trial of "spray-on" skin after the technique saved the life of a man with 90 per cent burns.
In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration found significant gaps in participation among those aged 75 and older when considered against the incidence of these malignancies in this age group, according to research being presented today during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation treatment," which has attracted intense interest in the global MS community, does not improve patient outcomes. In a few cases, the treatment made symptoms worse.
› Verified 8 days ago
| Entity Name | Silver Hill Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982658035 PECOS PAC ID: 8628039393 Enrollment ID: O20041026000195 |
News Archive
Orthofix International announced today that its Sports Medicine Division, Breg, has launched the FUSION® XT knee brace with its innovative new AirTech™ system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.
British doctors are about to conduct the first major trial of "spray-on" skin after the technique saved the life of a man with 90 per cent burns.
In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration found significant gaps in participation among those aged 75 and older when considered against the incidence of these malignancies in this age group, according to research being presented today during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation treatment," which has attracted intense interest in the global MS community, does not improve patient outcomes. In a few cases, the treatment made symptoms worse.
› Verified 8 days ago
| Entity Name | St. Vincent's Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043544489 PECOS PAC ID: 6204977218 Enrollment ID: O20100112000538 |
News Archive
Orthofix International announced today that its Sports Medicine Division, Breg, has launched the FUSION® XT knee brace with its innovative new AirTech™ system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.
British doctors are about to conduct the first major trial of "spray-on" skin after the technique saved the life of a man with 90 per cent burns.
In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration found significant gaps in participation among those aged 75 and older when considered against the incidence of these malignancies in this age group, according to research being presented today during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation treatment," which has attracted intense interest in the global MS community, does not improve patient outcomes. In a few cases, the treatment made symptoms worse.
› Verified 8 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Orthofix International announced today that its Sports Medicine Division, Breg, has launched the FUSION® XT knee brace with its innovative new AirTech™ system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.
British doctors are about to conduct the first major trial of "spray-on" skin after the technique saved the life of a man with 90 per cent burns.
In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration found significant gaps in participation among those aged 75 and older when considered against the incidence of these malignancies in this age group, according to research being presented today during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation treatment," which has attracted intense interest in the global MS community, does not improve patient outcomes. In a few cases, the treatment made symptoms worse.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Theddeus Iheanacho, MD 203 Broad St, Suite C-4, Milford, CT 06460-4751 Ph: (203) 874-0593 | Dr Theddeus Iheanacho, MD 203 Broad St, Suite C-4, Milford, CT 06460-4751 Ph: (203) 874-0593 |
News Archive
Orthofix International announced today that its Sports Medicine Division, Breg, has launched the FUSION® XT knee brace with its innovative new AirTech™ system. Designed to improve comfort and fit, AirTech is a complete system of air mesh vents and grooved channel frame pads that increase airflow throughout the brace. The system allows cool air in and moves warm air and moisture away from the skin, improving patient comfort. The new pad technology is also designed to reduce pinching and help alleviate pressure points.
British doctors are about to conduct the first major trial of "spray-on" skin after the technique saved the life of a man with 90 per cent burns.
In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration found significant gaps in participation among those aged 75 and older when considered against the incidence of these malignancies in this age group, according to research being presented today during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation treatment," which has attracted intense interest in the global MS community, does not improve patient outcomes. In a few cases, the treatment made symptoms worse.
› Verified 8 days ago
Christine Elaine Desmond, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 949 Bridgeport Ave, Milford, CT 06460 Phone: 203-878-6365 | |
Dr. Ubong Jackson Udoyen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 58 Augusta Dr, Milford, CT 06461 Phone: 803-269-7381 | |
Dr. Howard Feldman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 16 Rock Rd, Milford, CT 06460 Phone: 203-874-0895 | |
Terrell David Holloway, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 472 Wheelers Farms Rd Ste 306, Milford, CT 06461 Phone: 203-701-9737 | |
Donna W Klimowicz, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 949 Bridgeport Ave, Milford, CT 06460 Phone: 203-878-6365 | |
Dr. Burton G. Austen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 New Haven Avenue, Milford, CT 06460 Phone: 212-614-1011 Fax: 203-389-9896 | |
Lisa Harding, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 472 Wheelers Farms Rd Ste 306, Milford, CT 06461 Phone: 563-676-8923 Fax: 859-545-5013 |